321 related articles for article (PubMed ID: 30316910)
1. Study on Urine Metabolic Profile of Aβ25-35-Induced Alzheimer's Disease Using UHPLC-Q-TOF-MS.
Liu Y; Wei M; Yue K; Hu M; Li S; Men L; Pi Z; Liu Z; Liu Z
Neuroscience; 2018 Dec; 394():30-43. PubMed ID: 30316910
[TBL] [Abstract][Full Text] [Related]
2. Pharmacodynamic and urinary metabolomics studies on the mechanism of Schisandra polysaccharide in the treatment of Alzheimer's disease.
Liu Y; Liu Z; Wei M; Hu M; Yue K; Bi R; Zhai S; Pi Z; Song F; Liu Z
Food Funct; 2019 Jan; 10(1):432-447. PubMed ID: 30623955
[TBL] [Abstract][Full Text] [Related]
3. Urinary and plasmatic metabolomics strategy to explore the holistic mechanism of lignans in S. chinensis in treating Alzheimer's disease using UPLC-Q-TOF-MS.
Wei M; Liu Z; Liu Y; Li S; Hu M; Yue K; Liu T; He Y; Pi Z; Liu Z; Song F
Food Funct; 2019 Sep; 10(9):5656-5668. PubMed ID: 31433414
[TBL] [Abstract][Full Text] [Related]
4. Serum and urine metabolomics based on UPLC-QTOF/MS reveal the effect and potential mechanism of "schisandra-evodia" herb pair in the treatment of Alzheimer's disease.
Pang C; Wang R; Liu K; Yuan X; Ni J; Cao Q; Chen Y; Dong PL; Han H
Biomed Chromatogr; 2024 Jul; 38(7):e5882. PubMed ID: 38649307
[TBL] [Abstract][Full Text] [Related]
5. Subtle learning and memory impairment in an idiopathic rat model of Alzheimer's disease utilizing cholinergic depletions and β-amyloid.
Deibel SH; Weishaupt N; Regis AM; Hong NS; Keeley RJ; Balog RJ; Bye CM; Himmler SM; Whitehead SN; McDonald RJ
Brain Res; 2016 Sep; 1646():12-24. PubMed ID: 27208489
[TBL] [Abstract][Full Text] [Related]
6. Protective effects of Alpinae Oxyphyllae Fructus extracts on lipopolysaccharide-induced animal model of Alzheimer's disease.
Wang Y; Wang M; Fan K; Li T; Yan T; Wu B; Bi K; Jia Y
J Ethnopharmacol; 2018 May; 217():98-106. PubMed ID: 29447949
[TBL] [Abstract][Full Text] [Related]
7. Effect of Tong Luo Jiu Nao on Aβ-degrading enzymes in AD rat brains.
Liu Y; Hua Q; Lei H; Li P
J Ethnopharmacol; 2011 Sep; 137(2):1035-46. PubMed ID: 21798326
[TBL] [Abstract][Full Text] [Related]
8. Isorhynchophylline treatment improves the amyloid-β-induced cognitive impairment in rats via inhibition of neuronal apoptosis and tau protein hyperphosphorylation.
Xian YF; Mao QQ; Wu JC; Su ZR; Chen JN; Lai XP; Ip SP; Lin ZX
J Alzheimers Dis; 2014; 39(2):331-46. PubMed ID: 24164737
[TBL] [Abstract][Full Text] [Related]
9. Ginsenosides attenuate d-galactose- and AlCl
Zhang Y; Pi Z; Song F; Liu Z
J Ethnopharmacol; 2016 Dec; 194():188-195. PubMed ID: 27612432
[TBL] [Abstract][Full Text] [Related]
10. A UPLC-TOF/MS-based metabolomics study of rattan stems of Schisandra chinensis effects on Alzheimer's disease rats model.
Yang BY; Tan JY; Liu Y; Liu B; Jin S; Guo HW; Kuang HX
Biomed Chromatogr; 2018 Feb; 32(2):. PubMed ID: 28664556
[TBL] [Abstract][Full Text] [Related]
11. Changes in the prefrontal cortex after the hippocampus was injected with Aβ
Wang Y; Sheng H; Zhao J; Guo L; Liu J; Xu J; Liu Q; Huang J; Jiang R; Gan S; Qiu G; Lu W; Xu S; Zhu S
Neurosci Lett; 2021 Jan; 741():135453. PubMed ID: 33186609
[TBL] [Abstract][Full Text] [Related]
12. Thymoquinone administration ameliorates Alzheimer's disease-like phenotype by promoting cell survival in the hippocampus of amyloid beta
Elibol B; Beker M; Terzioglu-Usak S; Dalli T; Kilic U
Phytomedicine; 2020 Dec; 79():153324. PubMed ID: 32920292
[TBL] [Abstract][Full Text] [Related]
13. Lixisenatide rescues spatial memory and synaptic plasticity from amyloid β protein-induced impairments in rats.
Cai HY; Hölscher C; Yue XH; Zhang SX; Wang XH; Qiao F; Yang W; Qi JS
Neuroscience; 2014 Sep; 277():6-13. PubMed ID: 24583037
[TBL] [Abstract][Full Text] [Related]
14. Protective effects of kinetin against aluminum chloride and D-galactose induced cognitive impairment and oxidative damage in mouse.
Wei Y; Liu D; Zheng Y; Li H; Hao C; Ouyang W
Brain Res Bull; 2017 Sep; 134():262-272. PubMed ID: 28867383
[TBL] [Abstract][Full Text] [Related]
15. Rapid Identification of Tanshinone IIA Metabolites in an Amyloid-β
Liang S; Wang Z; Yuan J; Zhang J; Dai X; Qin F; Zhang J; Sun Y
Molecules; 2019 Jul; 24(14):. PubMed ID: 31315255
[TBL] [Abstract][Full Text] [Related]
16. Brain-targeted Tet-1 peptide-PLGA nanoparticles for berberine delivery against STZ-induced Alzheimer's disease in a rat model: Alleviation of hippocampal synaptic dysfunction, Tau pathology, and amyloidogenesis.
Saleh SR; Abd-Elmegied A; Aly Madhy S; Khattab SN; Sheta E; Elnozahy FY; Mehanna RA; Ghareeb DA; Abd-Elmonem NM
Int J Pharm; 2024 Jun; 658():124218. PubMed ID: 38734273
[TBL] [Abstract][Full Text] [Related]
17. Alzheimer's disease like pathology induced six weeks after aggregated amyloid-beta injection in rats: increased oxidative stress and impaired long-term memory with anxiety-like behavior.
Sharma S; Verma S; Kapoor M; Saini A; Nehru B
Neurol Res; 2016 Sep; 38(9):838-50. PubMed ID: 27431920
[TBL] [Abstract][Full Text] [Related]
18. Metabolomics approach to explore the effects of Kai-Xin-San on Alzheimer's disease using UPLC/ESI-Q-TOF mass spectrometry.
Chu H; Zhang A; Han Y; Lu S; Kong L; Han J; Liu Z; Sun H; Wang X
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Mar; 1015-1016():50-61. PubMed ID: 26896572
[TBL] [Abstract][Full Text] [Related]
19. Riluzole ameliorates learning and memory deficits in Aβ25-35-induced rat model of Alzheimer's disease and is independent of cholinoceptor activation.
Mokhtari Z; Baluchnejadmojarad T; Nikbakht F; Mansouri M; Roghani M
Biomed Pharmacother; 2017 Mar; 87():135-144. PubMed ID: 28049095
[TBL] [Abstract][Full Text] [Related]
20. Hypercholesterolemia accelerates amyloid β-induced cognitive deficits.
Park SH; Kim JH; Choi KH; Jang YJ; Bae SS; Choi BT; Shin HK
Int J Mol Med; 2013 Mar; 31(3):577-82. PubMed ID: 23314909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
